Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Françoise Dantzer is active.

Publication


Featured researches published by Françoise Dantzer.


Nature Reviews Molecular Cell Biology | 2006

Poly(ADP-ribose): novel functions for an old molecule

Valérie Schreiber; Françoise Dantzer; Jean-Christophe Amé; Gilbert de Murcia

The addition to proteins of the negatively charged polymer of ADP-ribose (PAR), which is synthesized by PAR polymerases (PARPs) from NAD+, is a unique post-translational modification. It regulates not only cell survival and cell-death programmes, but also an increasing number of other biological functions with which novel members of the PARP family have been associated. These functions include transcriptional regulation, telomere cohesion and mitotic spindle formation during cell division, intracellular trafficking and energy metabolism.


The EMBO Journal | 2003

Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse

Josiane Ménissier-de Murcia; Michelle Ricoul; Laurence Tartier; Claude Niedergang; Aline Huber; Françoise Dantzer; Valérie Schreiber; Jean-Christophe Amé; Andrée Dierich; Marianne LeMeur; Laure Sabatier; Pierre Chambon; Gilbert de Murcia

The DNA damage‐dependent poly(ADP‐ribose) polymerases, PARP‐1 and PARP‐2, homo‐ and heterodimerize and are both involved in the base excision repair (BER) pathway. Here, we report that mice carrying a targeted disruption of the PARP‐2 gene are sensitive to ionizing radiation. Following alkylating agent treatment, parp‐2−/−‐derived mouse embryonic fibroblasts exhibit increased post‐replicative genomic instability, G2/M accumulation and chromosome mis‐segregation accompanying kinetochore defects. Moreover, parp‐1−/−parp‐2−/− double mutant mice are not viable and die at the onset of gastrulation, demonstrating that the expression of both PARP‐1 and PARP‐2 and/or DNA‐dependent poly(ADP‐ribosyl) ation is essential during early embryogenesis. Interestingly, specific female embryonic lethality is observed in parp‐1+/−parp‐2−/− mutants at E9.5. Meta phase analyses of E8.5 embryonic fibroblasts highlight a specific instability of the X chromosome in those females, but not in males. Together, these results support the notion that PARP‐1 and PARP‐2 possess both overlapping and non‐redundant functions in the maintenance of genomic stability.


Molecular and Cellular Biology | 2004

Functional Interaction between Poly(ADP-Ribose) Polymerase 2 (PARP-2) and TRF2: PARP Activity Negatively Regulates TRF2

Françoise Dantzer; Marie-Josèphe Giraud-Panis; Isabel Jaco; Jean-Christophe Amé; Inès Schultz; Maria A. Blasco; Catherine-Elaine Koering; Eric Gilson; Josiane Ménissier-de Murcia; Gilbert de Murcia; Valérie Schreiber

ABSTRACT The DNA damage-dependent poly(ADP-ribose) polymerase-2 (PARP-2) is, together with PARP-1, an active player of the base excision repair process, thus defining its key role in genome surveillance and protection. Telomeres are specialized DNA-protein structures that protect chromosome ends from being recognized and processed as DNA strand breaks. In mammals, telomere protection depends on the T2AG3 repeat binding protein TRF2, which has been shown to remodel telomeres into large duplex loops (t-loops). In this work we show that PARP-2 physically binds to TRF2 with high affinity. The association of both proteins requires the N-terminal domain of PARP-2 and the myb domain of TRF2. Both partners colocalize at promyelocytic leukemia bodies in immortalized telomerase-negative cells. In addition, our data show that PARP activity regulates the DNA binding activity of TRF2 via both a covalent heteromodification of the dimerization domain of TRF2 and a noncovalent binding of poly(ADP-ribose) to the myb domain of TRF2. PARP-2−/− primary cells show normal telomere length as well as normal telomerase activity compared to wild-type cells but display a spontaneously increased frequency of chromosome and chromatid breaks and of ends lacking detectable T2AG3 repeats. Altogether, these results suggest a functional role of PARP-2 activity in the maintenance of telomere integrity.


Cell Cycle | 2006

Control of AIF-mediated cell death by the functional interplay of SIRT1 and PARP-1 in response to DNA damage

Ullas Kolthur-Seetharam; Françoise Dantzer; Michael W. McBurney; Gilbert de Murcia; Paolo Sassone-Corsi

Cell survival after genotoxic stress is determined by a counterbalance of pro- andanti-death factors. Sirtuins (SIRTs) are deacetylases that promote cell survival whereaspoly(ADP-ribose) polymerases (PARPs) can act both as survival and death inducingfactor and the two protein families are strictly dependent on NAD+ for their activities.Here we report that SIRT1 modulates PARP-1 activity upon DNA damage. Activation ofSIRT1 by resveratrol leads to reduced PARP-1 activity and there is a drastic increase inPAR synthesis in sirt1-null cells. The unbalanced regulation of PARP-1 in the absence ofSIRT1 results in AIF (apoptosis inducing factor)-mediated cell death. Our findingsestablish a functional link between the two NAD+-dependent enzyme systems andprovide a physiological interpretation for the mechanism of death in cells lacking SIRT1.


Proceedings of the National Academy of Sciences of the United States of America | 2011

Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression

Christian Boehler; Laurent Gauthier; Oliver Mortusewicz; Denis Biard; Jean-Michel Saliou; Anne Bresson; Sarah Sanglier-Cianférani; Susan Smith; Valérie Schreiber; François D. Boussin; Françoise Dantzer

The ADP ribosyl transferase [poly(ADP-ribose) polymerase] ARTD3(PARP3) is a newly characterized member of the ARTD(PARP) family that catalyzes the reaction of ADP ribosylation, a key posttranslational modification of proteins involved in different signaling pathways from DNA damage to energy metabolism and organismal memory. This enzyme shares high structural similarities with the DNA repair enzymes PARP1 and PARP2 and accordingly has been found to catalyse poly(ADP ribose) synthesis. However, relatively little is known about its in vivo cellular properties. By combining biochemical studies with the generation and characterization of loss-of-function human and mouse models, we describe PARP3 as a newcomer in genome integrity and mitotic progression. We report a particular role of PARP3 in cellular response to double-strand breaks, most likely in concert with PARP1. We identify PARP3 as a critical player in the stabilization of the mitotic spindle and in telomere integrity notably by associating and regulating the mitotic components NuMA and tankyrase 1. Both functions open stimulating prospects for specifically targeting PARP3 in cancer therapy.


Cell Metabolism | 2014

NAD(+)-dependent activation of Sirt1 corrects the phenotype in a mouse model of mitochondrial disease.

Raffaele Cerutti; Eija Pirinen; Costanza Lamperti; Silvia Marchet; Anthony A. Sauve; Wei Li; Valerio Leoni; Eric A. Schon; Françoise Dantzer; Johan Auwerx; Carlo Viscomi; Massimo Zeviani

Summary Mitochondrial disorders are highly heterogeneous conditions characterized by defects of the mitochondrial respiratory chain. Pharmacological activation of mitochondrial biogenesis has been proposed as an effective means to correct the biochemical defects and ameliorate the clinical phenotype in these severely disabling, often fatal, disorders. Pathways related to mitochondrial biogenesis are targets of Sirtuin1, a NAD+-dependent protein deacetylase. As NAD+ boosts the activity of Sirtuin1 and other sirtuins, intracellular levels of NAD+ play a key role in the homeostatic control of mitochondrial function by the metabolic status of the cell. We show here that supplementation with nicotinamide riboside, a natural NAD+ precursor, or reduction of NAD+ consumption by inhibiting the poly(ADP-ribose) polymerases, leads to marked improvement of the respiratory chain defect and exercise intolerance of the Sco2 knockout/knockin mouse, a mitochondrial disease model characterized by impaired cytochrome c oxidase biogenesis. This strategy is potentially translatable into therapy of mitochondrial disorders in humans.


Trends in Molecular Medicine | 2008

Toward specific functions of poly(ADP-ribose) polymerase-2.

José Yélamos; Valérie Schreiber; Françoise Dantzer

Poly(ADP-ribose) polymerase-2 (PARP-2) belongs to a family of enzymes that catalyze poly(ADP-ribosyl)ation of proteins. PARP-1 and PARP-2 are so far the only PARP enzymes whose catalytic activity has been shown to be induced by DNA-strand breaks, providing strong support for key shared functions in the cellular response to DNA damage. Accordingly, clinical trials for cancer, using PARP inhibitors that target the conserved catalytic domain of PARP proteins, are now ongoing. However, recent data suggest unique functions for PARP-2 in specific processes, such as genome surveillance, spermatogenesis, adipogenesis and T cell development. Understanding these physiological roles might provide invaluable clues to the rational development and exploitation of specific PARP-2 inhibitor drugs in a clinical setting and the design of new therapeutic approaches in different pathophysiological conditions.


EMBO Reports | 2008

The expanding field of poly(ADP‐ribosyl)ation reactions

Antoinette Hakmé; Heng-Kuan Wong; Françoise Dantzer; Valérie Schreiber

Poly(ADP‐ribosyl)ation is a post‐translational modification of proteins that is mediated by poly(ADP‐ribose) polymerases (PARPs). Although the existence and nature of the nucleic acid‐like molecule poly(ADP‐ribose) (PAR) has been known for 40 years, understanding its biological functions—originally thought to be only the regulation of chromatin superstructure when DNA is broken—is still the subject of intense research. Here, we review the mechanisms controlling the biosynthesis of this complex macromolecule and some of its main biological functions, with an emphasis on the most recent advances and hypotheses that have developed in this rapidly growing field.


Experimental Cell Research | 2014

Poly(ADP-ribose) polymerases in double-strand break repair: focus on PARP1, PARP2 and PARP3.

Carole Beck; Isabelle Robert; Bernardo Reina-San-Martin; Valérie Schreiber; Françoise Dantzer

Poly(ADP-ribosyl)ation (PARylation) is a post-translational modification of proteins catalysed by Poly(ADP-ribose) polymerases (PARP). A wealth of recent advances in the biochemical and functional characterization of the DNA-dependent PARP family members have highlighted their key contribution in the DNA damage response network, the best characterized being the role of PARP1 and PARP2 in the resolution of single-strand breaks as part of the BER/SSBR process. How PARylation contributes to the repair of double-strand breaks is less well defined but has become recently the subject of significant research in the field. The aim of this review is to provide an overview of the current knowledge concerning the role of the DNA-activated PARP1, PARP2 and PARP3 in cellular response to double-strand breaks (DSB). In addition, we outline the biological significance of these properties in response to programmed DNA lesions formed during physiological processes such as antibody repertoire assembly and diversification.


Proceedings of the National Academy of Sciences of the United States of America | 2006

Poly(ADP-ribose) polymerase-2 contributes to the fidelity of male meiosis I and spermiogenesis

Françoise Dantzer; Manuel Mark; Delphine Quénet; Harry Scherthan; Aline Huber; Bodo Liebe; Lucia Monaco; Alexandra Chicheportiche; Paolo Sassone-Corsi; Gilbert de Murcia; Josiane Ménissier-de Murcia

Besides the established central role of poly(ADP-ribose) polymerase-1 (Parp-1) and Parp-2 in the maintenance of genomic integrity, accumulating evidence indicates that poly(ADP-ribosyl)ation may modulate epigenetic modifications under physiological conditions. Here, we provide in vivo evidence for the pleiotropic involvement of Parp-2 in both meiotic and postmeiotic processes. We show that Parp-2-deficient mice exhibit severely impaired spermatogenesis, with a defect in prophase of meiosis I characterized by massive apoptosis at pachytene and metaphase I stages. Although Parp-2−/− spermatocytes exhibit normal telomere dynamics and normal chromosome synapsis, they display defective meiotic sex chromosome inactivation associated with derailed regulation of histone acetylation and methylation and up-regulated X- and Y-linked gene expression. Furthermore, a drastically reduced number of crossover-associated Mlh1 foci are associated with chromosome missegregation at metaphase I. Moreover, Parp-2−/− spermatids are severely compromised in differentiation and exhibit a marked delay in nuclear elongation. Altogether, our findings indicate that, in addition to its well known role in DNA repair, Parp-2 exerts essential functions during meiosis I and haploid gamete differentiation.

Collaboration


Dive into the Françoise Dantzer's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gilbert de Murcia

École Normale Supérieure

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Delphine Quénet

École Normale Supérieure

View shared research outputs
Top Co-Authors

Avatar

Aurélia Noll

University of Strasbourg

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge